Bifunctional epoxide hydrolase 2
- Generic Name
- Bifunctional epoxide hydrolase 2
- Drug Type
- Biotech
- Unique Ingredient Identifier
- JEH09DQZ6V
- Background
Bifunctional epoxide hydrolase 2 is under investigation in clinical trial NCT00654966 (Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers).
Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers
Phase 2
Completed
- Conditions
- Heart Failure
- Interventions
- Drug: Urotensine II
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- Monash University
- Target Recruit Count
- 16
- Registration Number
- NCT00654966
- Locations
- 🇦🇺
Alfred Hospital, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath